Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)

KRX:019170 Financials Overview

Financials in millions KRW. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	233,797	234,681	221,094	200,229	209,288	189,237
Revenue Growth	5.08%	6.14%	10.42%	-4.33%	10.60%	-4.30%
Gross Profit Gross Profit Growth	102,402	102,671	81,804	80,277	77,973	77,388
Operating Income Operating Income Growth	15,655	14,255	-17,029	-47,392	-34,019	-14,306
Net Income Net Income Growth	10,096	8,454	-15,387	-57,325	-35,377	-11,584
Earnings Per Share EPS Growth	194.69	171.57	-301.00	-1118.28	-690.12	-225.97
EPS Growth	-	-	-	-	-	-

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	76,612	71,506	56,461	60,581	55,917	92,702
Total Debt Total Debt Growth	54,509	55,856	54,597	46,151	1,928	1,181
Net Cash (Debt) Net Cash Growth	22,102	15,650	1,864	14,430	53,988	91,521
Net Cash Growth	891.33%	739.66%	-87.08%	-73.27%	-41.01%	-51.54%
Net Cash Per Share Net Cash Per Share Growth	426.20	317.64	36.46	281.49	1053.18	1785.35

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	23,437	17,254	-15,155	-24,808	-26,444	-71,028
Capital Expenditures CapEx Growth	-3,075	-3,477	-5,569	-14,888	-5,323	-4,425
Free Cash Flow Free Cash Flow Growth	20,362	13,776	-20,724	-39,696	-31,767	-75,453
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	43.80%	43.75%	37.00%	40.09%	37.26%	40.89%
Operating Margin	6.70%	6.07%	-7.70%	-23.67%	-16.25%	-7.56%
Pretax Margin	4.43%	3.60%	-6.61%	-26.69%	-16.62%	-4.75%
Profit Margin	4.32%	3.60%	-6.96%	-28.63%	-16.90%	-6.12%
FCF Margin	8.71%	5.87%	-9.37%	-19.82%	-15.18%	-39.87%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 8, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	43.45	87.37	-	-	-	-
P/FCF Ratio	21.49	53.61	-	-	-	-
PS Ratio	1.87	3.15	2.44	3.53	5.38	8.74

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 7, 2026

Data Sources Report a data error